Amneal Pharmaceuticals, LLC
Quick facts
Marketed products
- Diclofenac Sodium Topical Gel, 1% · Pain Management / Rheumatology
Diclofenac sodium inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation and pain at the site of topical application.
Phase 3 pipeline
- Vehicle Diclofenac Sodium Topical Gel · Pain Management
Diclofenac sodium works by inhibiting the enzyme cyclooxygenase (COX), which is involved in the production of prostaglandins, leading to reduced inflammation and pain. - Voltaren Topical Gel, 1% · Musculoskeletal
Voltaren Topical Gel, 1% works by reducing inflammation and pain through the inhibition of prostaglandin synthesis.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Amneal Pharmaceuticals, LLC
What are Amneal Pharmaceuticals, LLC's marketed drugs?
Top marketed products include Diclofenac Sodium Topical Gel, 1%.
What is Amneal Pharmaceuticals, LLC's pipeline?
Amneal Pharmaceuticals, LLC has 2 drugs in Phase 3, 0 in Phase 2, 2 in Phase 1. Late-stage candidates include Vehicle Diclofenac Sodium Topical Gel, Voltaren Topical Gel, 1%.
Related
- Diclofenac Sodium Topical Gel, 1% · Pain Management / Rheumatology
- Sector hub: All tracked pharma companies